Scholar Rock's Isembyld Is First Muscle-Targeting SMA Drug
The FDA approval gives spinal muscular atrophy patients a new option that acts directly on muscle tissue.
Clinical AI, drug discovery, devices, and regulatory approvals.
The FDA approval gives spinal muscular atrophy patients a new option that acts directly on muscle tissue.
A suspected contaminated batch of local brew in southern Nigeria has killed at least 48 people and sent roughly 100 others for treatment, underscoring dangers of unregulated alcohol.
A U.S. cohort study finds that children not eligible for RSV immunization still account for a substantial share of severe RSV cases.
An upcoming healthcare conference will examine how consumer demand is reshaping the role of wearable devices.
Health secretary Kennedy announced a new research fund aimed at accelerating autism diagnoses, calling the current model outdated.
Plastic surgeon Kavitha Ranganathan argues that young male patients are responding rationally to a profit-driven aesthetic industry.
Attacks on hospitals in Sudan have made life-saving treatment for cancer and chronic illness nearly impossible, forcing patients to risk their lives to seek care.
A single protein's decline may drive multiple aging effects, and restoring it could point to new anti-aging targets.
A quarter of MASLD cirrhosis cases occur before age 50, with genetic and metabolic factors playing a key role.
The $500 ACA refunds give some enrollees immediate cash but do little to solve systemic healthcare affordability problems.
A near-miss with breast cancer led Ariel Ganz to co-found Arben Ventures, a precision health and longevity fund that has backed 83 early-stage startups in three years.
A new report warns that hospitals are deploying agentic AI tools faster than the guardrails needed to protect patients.
Proposed revisions to residency standards could weaken existing work-hour protections, alarming trainees and advocates.
The latest Readout LOUD episode examines Definium's psychedelics data and a court ruling that gives international researchers temporary relief.
A new survey finds that employed doctors face greater distress, driven by workload and administrative burden.
The insurer will consolidate all cancer care preapprovals into a single upfront request, easing administrative burden on physicians.
A new STAT newsletter reports that the FDA cannot efficiently recruit because existing employees are already stretched too thin.
A new analysis argues that patient warming and positioning, long treated as separate concerns, must be coordinated for robotic-assisted procedures.